Evoke Pharma
EVOK
EVOK
30 hedge funds and large institutions have $6.75M invested in Evoke Pharma in 2020 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 9 increasing their positions, 5 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0.02% more ownership
Funds ownership: 0.05% → 0.07% (+0.02%)
23% less capital invested
Capital invested by funds: $8.74M → $6.75M (-$1.99M)
Holders
30
Holding in Top 10
–
Calls
$703K
Puts
$381K
Top Buyers
| 1 | +$1.06M | |
| 2 | +$425K | |
| 3 | +$111K | |
| 4 |
SM
Sabby Management
Miami Beach,
Florida
|
+$110K |
| 5 |
Group One Trading
Chicago,
Illinois
|
+$72.3K |
Top Sellers
| 1 | -$108K | |
| 2 | -$24.2K | |
| 3 | -$15.8K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$9.66K |
| 5 |
DWA
Dorsey Wright & Associates
Pasadena,
California
|
-$8K |